Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: John J. Frawley who wrote (1789)	4/13/1999 12:11:00 AM
From: Marshall Teitelbaum	Respond to of 2205

John, Not sure I can give you a total answer. Haven't had that much time to fully assess myself given my day today, but first here's a copy of today's action: quote.yahoo.com You see two major volume spikes, although volume was heavy all day, and you see testing above 3 and below 3 over a dozen times each. There were some large trades, but the average trade size today was still not all that large. The close over 3, just nipping over 3 again at the end of the day, might be an aberration and drop back to the mid-upper 2s before likely consolidating, or it could be a sign of things to come, given the length of time since closing over 3(even the bid) and the 200 day mva...although I wouldn't bet on it just yet, even though it would be nice and I wouldn't necessarily like being right about this. The heavy volume isn't telling us all yet.....how much churning, how much preferred shareholder involvement(if any), how much action begot more action(in play?), how much might be based on a little good 2Q momentum(fine for last week's movement, but today doesn't fit this), and/or what is going on behind the scenes(anything we don't necessarily know of that maybe someone else does). Continued heavy volume would likely help get through and stay through the 3 barrier, but this wasn't totally the kind of happy volume(buying and almost nothing but buying) we all might like, or else we wouldn't still be at 3. So some of the questions will be answered tomorrow about the immediate price and volume, and then we wait and see what type of news comes out of this. One thing is for sure....the msnbc article and the cnbc appearance weren't the reasons for the bulk of today, even though they couldn't have hurt. Anyway, without getting into further details or rambling, time to hit the sake and simply be patient here. Have a good night. regards, Marshall

To: John J. Frawley who wrote (1789)	4/13/1999 7:41:00 AM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

John, FWIW, looks like ATIS isn't the only one with increased price and volume in the last day: finance.uk.yahoo.com.*L&d=t That "sake" was a typo, btw, as far as you know! Also, looks like some lower-priced good science biotechs saw a little more action than usual in a posiive manner yesterday, possibly partially because of some of the tech weakness. MLT

To: John J. Frawley who wrote (1789)	4/13/1999 11:08:00 PM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

John, One other thing to consider....funded ATIS study just hit The Journal of Bone and Joint Surgery. "A living cartilage/bone construct developed and maintained its structure throughout the 40-week study, and provides evidence that whole joint structures can potentially be created by using a combination of cells and biodegradable polymers. The success of this research helps to demonstrate the feasibility of replacing total joints with living tissue engineered constructs in the future." Extremely interesting, especially for the long-term. There should be little need for artificial joints 10 years and beyond from now if all pans out, except maybe in acute situations. Of course, managed care on the other hand.......We'll cover a right knee, but no left knees unless you can show us that a right knee has failed first! :) Regards, Marshall